CH630257A5 - Sustained release formulation - Google Patents
Sustained release formulation Download PDFInfo
- Publication number
- CH630257A5 CH630257A5 CH277676A CH277676A CH630257A5 CH 630257 A5 CH630257 A5 CH 630257A5 CH 277676 A CH277676 A CH 277676A CH 277676 A CH277676 A CH 277676A CH 630257 A5 CH630257 A5 CH 630257A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formulation
- present
- hydrocolloid
- gastric juice
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55910775A | 1975-03-17 | 1975-03-17 | |
US65800376A | 1976-02-13 | 1976-02-13 | |
KR7600645A KR800001387B1 (en) | 1975-03-17 | 1976-03-16 | Process for preparing sustained release formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
CH630257A5 true CH630257A5 (en) | 1982-06-15 |
Family
ID=27348140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH277676A CH630257A5 (en) | 1975-03-17 | 1976-03-05 | Sustained release formulation |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS51115910A (nl) |
AR (1) | AR222624A1 (nl) |
AT (1) | AT353415B (nl) |
AU (1) | AU505355B2 (nl) |
CA (1) | CA1073358A (nl) |
CH (1) | CH630257A5 (nl) |
DD (1) | DD124102A5 (nl) |
DE (1) | DE2611041A1 (nl) |
DK (1) | DK148344C (nl) |
ES (1) | ES446075A1 (nl) |
FR (1) | FR2304354A1 (nl) |
GB (1) | GB1546448A (nl) |
GR (1) | GR60341B (nl) |
IE (1) | IE43083B1 (nl) |
LU (1) | LU74558A1 (nl) |
MC (1) | MC1101A1 (nl) |
NL (1) | NL190313C (nl) |
NZ (1) | NZ180321A (nl) |
PH (1) | PH14927A (nl) |
PT (1) | PT64907B (nl) |
SE (1) | SE433804B (nl) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
CH649215A5 (de) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
CH666406A5 (de) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. |
KR850700212A (ko) * | 1984-03-21 | 1985-12-26 | 죠지 드모트 | 서방성 약제학적 캼셀제 |
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
HU195729B (en) * | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
GB8524135D0 (en) * | 1985-10-01 | 1985-11-06 | Sandoz Ltd | Darodipine compositions |
NL194822C (nl) * | 1985-10-01 | 2003-04-03 | Novartis Ag | Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan. |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
DE69207656T2 (de) * | 1991-01-30 | 1996-10-17 | Wellcome Found | Wasserlösliche tabletten |
DE69226950T2 (de) * | 1991-04-08 | 1999-05-12 | Nippon Shinyaku Co Ltd | Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt |
CA2132012C (en) * | 1992-03-25 | 2003-04-22 | John W. Shell | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
CA2175225C (en) * | 1993-10-29 | 2004-09-21 | Keith Graeme Hutchison | Gelatin capsule fill able to foam |
WO1995011668A1 (en) * | 1993-10-29 | 1995-05-04 | Reckitt & Colman Products Limited | Gelatin capsule fill able to foam |
JPH10500412A (ja) * | 1994-05-13 | 1998-01-13 | スミスクライン・ビーチャム・コーポレイション | カルシウム摂取を増加させるための方法および組成物 |
JPH10509981A (ja) * | 1994-12-01 | 1998-09-29 | サイバス ファーマシューティカル,インコーポレイティド | 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出 |
FR2820318B1 (fr) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu |
FR2820319B3 (fr) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu |
EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1059624B (de) * | 1954-11-11 | 1959-06-18 | Dr Knut Jacobus Sundman | Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form |
JPS5512411B2 (nl) * | 1974-03-12 | 1980-04-02 | ||
DE2439538C3 (de) * | 1974-08-17 | 1980-07-17 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe |
-
1976
- 1976-03-05 CH CH277676A patent/CH630257A5/de not_active IP Right Cessation
- 1976-03-11 IE IE508/76A patent/IE43083B1/en unknown
- 1976-03-15 GR GR50306A patent/GR60341B/el unknown
- 1976-03-15 FR FR7607363A patent/FR2304354A1/fr active Granted
- 1976-03-15 LU LU74558A patent/LU74558A1/xx unknown
- 1976-03-15 NZ NZ180321A patent/NZ180321A/xx unknown
- 1976-03-15 MC MC761182A patent/MC1101A1/xx unknown
- 1976-03-16 PT PT64907A patent/PT64907B/pt unknown
- 1976-03-16 DD DD191877A patent/DD124102A5/xx unknown
- 1976-03-16 CA CA248,018A patent/CA1073358A/en not_active Expired
- 1976-03-16 SE SE7603325A patent/SE433804B/xx not_active IP Right Cessation
- 1976-03-16 ES ES446075A patent/ES446075A1/es not_active Expired
- 1976-03-16 AU AU12049/76A patent/AU505355B2/en not_active Expired
- 1976-03-16 DK DK113676A patent/DK148344C/da not_active IP Right Cessation
- 1976-03-16 AT AT192276A patent/AT353415B/de not_active IP Right Cessation
- 1976-03-16 JP JP51027758A patent/JPS51115910A/ja active Granted
- 1976-03-16 DE DE19762611041 patent/DE2611041A1/de active Granted
- 1976-03-16 GB GB10482/76A patent/GB1546448A/en not_active Expired
- 1976-03-17 NL NLAANVRAGE7602776,A patent/NL190313C/nl not_active IP Right Cessation
- 1976-03-17 AR AR262597A patent/AR222624A1/es active
- 1976-03-29 PH PH18224A patent/PH14927A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GR60341B (en) | 1978-05-17 |
GB1546448A (en) | 1979-05-23 |
DE2611041A1 (de) | 1976-10-14 |
PT64907B (fr) | 1978-03-24 |
CA1073358A (en) | 1980-03-11 |
MC1101A1 (fr) | 1977-02-04 |
ATA192276A (de) | 1979-04-15 |
AU1204976A (en) | 1977-09-22 |
AR222624A1 (es) | 1981-06-15 |
IE43083B1 (en) | 1980-12-17 |
NL190313B (nl) | 1993-08-16 |
LU74558A1 (nl) | 1977-09-27 |
DK113676A (da) | 1976-09-18 |
PH14927A (en) | 1982-01-29 |
AU505355B2 (en) | 1979-11-15 |
DD124102A5 (nl) | 1977-02-02 |
NL190313C (nl) | 1994-01-17 |
AT353415B (de) | 1979-11-12 |
IE43083L (en) | 1976-09-17 |
DK148344C (da) | 1985-11-04 |
SE7603325L (sv) | 1976-09-18 |
ES446075A1 (es) | 1977-09-16 |
SE433804B (sv) | 1984-06-18 |
JPS51115910A (en) | 1976-10-13 |
FR2304354B1 (nl) | 1979-04-27 |
FR2304354A1 (fr) | 1976-10-15 |
NZ180321A (en) | 1978-06-20 |
PT64907A (fr) | 1976-04-01 |
JPS638084B2 (nl) | 1988-02-19 |
DK148344B (da) | 1985-06-17 |
NL7602776A (nl) | 1976-09-21 |
DE2611041C2 (nl) | 1988-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2611041C2 (nl) | ||
DE69821553T2 (de) | Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat | |
DE69624907T3 (de) | Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten | |
DE3811114C2 (de) | Zweischichtige Dosierungsform zur Abgabe eines Wirkstoffs | |
AT398165B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung | |
DE69629797T2 (de) | Matrix zur gesteuerten freisetzung von arzneistoffen | |
DE69727922T2 (de) | Schnell zerfallende orale dosierungsform | |
EP0068191B2 (de) | Orale Dipyridamolformen | |
DE1617374C2 (de) | Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung | |
DE3309516C2 (nl) | ||
US4167558A (en) | Novel sustained release tablet formulations | |
US4140755A (en) | Sustained release tablet formulations | |
EP0486863B1 (de) | Antazida-Zubereitung mit verlängerter Magenverweilzeit | |
DE60117801T2 (de) | Pharmazeutische zusammensetzung mit gesteuerter freigabe und verzögerter absorption | |
DE69820287T2 (de) | Pharmazeutische Zubereitung, die Chlodronat als Wirkstoff und silicifizierte mikrokristalline Cellulose als Exipienten umfasst | |
US4126672A (en) | Sustained release pharmaceutical capsules | |
DE60207383T2 (de) | Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen | |
DE2808514A1 (de) | Nitrofurantoin enthaltende tablette | |
AT398166B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen) | |
CH639845A5 (en) | Solid depot pharmaceutical preparations and process for their production | |
CH690955A5 (de) | Oxybutynin umfassende Arzneiform. | |
DE4406424A1 (de) | Expandierbare Arzneiformen | |
DE3246492A1 (de) | Verfahren zur herstellung therapeutischer praeparate auf der basis von hydroxypropylmethylzellulose mit verlaengertem freisetzungsverlauf | |
DE2908847A1 (de) | Pharmazeutische zubereitung mit verzoegerter freigabe | |
DE69815856T2 (de) | Cefadroxilmonohydrat tablettenformulierung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUE | Assignment |
Owner name: F. HOFFMANN-LA ROCHE AG |
|
PL | Patent ceased |